Symptom improvement in patients treated for recurrent or progressive low-grade glioma

被引:0
|
作者
Dunbar, Erin [1 ]
Kleinberg, Lawrence [1 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:478 / 479
页数:2
相关论文
共 50 条
  • [1] Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma
    Neevika Manoharan
    Jungwhan Choi
    Christine Chordas
    Mary Ann Zimmerman
    Jacqueline Scully
    Jessica Clymer
    Mariella Filbin
    Nicole J. Ullrich
    Pratiti Bandopadhayay
    Susan N. Chi
    Kee Kiat Yeo
    Journal of Neuro-Oncology, 2020, 149 : 253 - 262
  • [2] Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma
    Manoharan, Neevika
    Choi, Jungwhan
    Chordas, Christine
    Zimmerman, Mary Ann
    Scully, Jacqueline
    Clymer, Jessica
    Filbin, Mariella
    Ullrich, Nicole J.
    Bandopadhayay, Pratiti
    Chi, Susan N.
    Yeo, Kee Kiat
    JOURNAL OF NEURO-ONCOLOGY, 2020, 149 (02) : 253 - 262
  • [3] Temozolomide in children with progressive low-grade glioma
    Gururangan, Sridharan
    Fisher, Michael J.
    Allen, Jeffrey C.
    Herndon, James E., II
    Quinn, Jennifer A.
    Reardon, David A.
    Vredenburgh, James J.
    Desjardins, Annick
    Phillips, Peter C.
    Watral, Melody A.
    Krauser, Jeanne M.
    Friedman, Allan H.
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2007, 9 (02) : 161 - 168
  • [4] Temozolomide in the treatment of progressive low-grade glioma
    Saba, N
    Paes, V
    Galeana, J
    Pascalicchio, AP
    Cavalheiro, S
    NEURO-ONCOLOGY, 2004, 6 (04) : 465 - 465
  • [5] Phase II trial of temozolomide in patients with progressive low-grade glioma
    Quinn, JA
    Reardon, DA
    Friedman, AH
    Rich, JN
    Sampson, JH
    Provenzale, JM
    McLendon, RE
    Gururangan, S
    Bigner, DD
    Herndon, JE
    Avgeropoulos, N
    Finlay, J
    Tourt-Uhlig, S
    Affronti, ML
    Evans, B
    Stafford-Fox, V
    Zaknoen, S
    Friedman, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) : 646 - 651
  • [6] Response to trametinib treatment in progressive pediatric low-grade glioma patients
    Florian Selt
    Cornelis M. van Tilburg
    Brigitte Bison
    Philipp Sievers
    Inga Harting
    Jonas Ecker
    Kristian W. Pajtler
    Felix Sahm
    Annabelle Bahr
    Michèle Simon
    David T. W. Jones
    Lennart Well
    Victor-Felix Mautner
    David Capper
    Pablo Hernáiz Driever
    Astrid Gnekow
    Stefan M. Pfister
    Olaf Witt
    Till Milde
    Journal of Neuro-Oncology, 2020, 149 : 499 - 510
  • [7] Response to trametinib treatment in progressive pediatric low-grade glioma patients
    Selt, Florian
    van Tilburg, Cornelis M.
    Bison, Brigitte
    Sievers, Philipp
    Harting, Inga
    Ecker, Jonas
    Pajtler, Kristian W.
    Sahm, Felix
    Bahr, Annabelle
    Simon, Michele
    Jones, David T. W.
    Well, Lennart
    Mautner, Victor-Felix
    Capper, David
    Hernaiz Driever, Pablo
    Gnekow, Astrid
    Pfister, Stefan M.
    Witt, Olaf
    Milde, Till
    JOURNAL OF NEURO-ONCOLOGY, 2020, 149 (03) : 499 - 510
  • [8] Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low-grade glioma
    Hamimed, Mourad
    Gattacceca, Florence
    Andre, Nicolas
    Tresch-Bruneel, Emmanuelle
    Probst, Alicia
    Chastagner, Pascal
    Pagnier, Anne
    De Carli, Emilie
    Entz-Werle, Natacha
    Grill, Jacques
    Aerts, Isabelle
    Frappaz, Didier
    Bertozzi-Salamon, Anne-Isabelle
    Solas, Caroline
    Leblond, Pierre
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (05) : 2096 - 2117
  • [9] Treatment of adults with recurrent progressive low-grade glioma using imatinib mesylate and hydroxyurea
    Salacz, M. E.
    Desjardins, A.
    Quinn, J. A.
    Rich, J. N.
    Vredenburgh, J. J.
    Sathornsumetee, S.
    Goli, K.
    Friedman, H. S.
    Reardon, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Pilot study of vinblastine in patients with recurrent and refractory low-grade glioma
    Bouffet, E
    Goldman, S
    Jakacki, R
    Garre, ML
    Foreman, N
    Cairney, E
    Etzl, M
    Tariq, N
    Hargrave, D
    NEURO-ONCOLOGY, 2004, 6 (04) : 450 - 450